Thanks, Andrew Speaker

One man with TB shows the world why the quarantine system often doesn't work.

Written byGlenn McGee
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Last month, one man single-handedly exposed the fact that the US public health system doesn't always do its job. Infected with a deadly drug-resistant strain of tuberculosis, Andrew Speaker traveled to several countries, exposing more than 600 people on two flights, even though a scan of his passport brought up a warning to keep him in custody and contact health authorities.

One could argue that it's the public health system's fault that he developed extremely drug-resistant tuberculosis (XDR-TB) in the first place. TB becomes resistant to antibiotics when improperly treated, and XDR-TB is resistant to at least two main first-line drugs and at least three of the six second-line drugs. If we thoroughly treated TB in its less deadly-form, the US Centers for Disease Control and Prevention wouldn't have had to institute its first federal quarantine in nearly 45 years.

It is clear that our current system of directly observed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies